67 Exits

Seven Cleveland bioscience companies were in acquired in 2017, including a unicorn, CoverMyMeds, acquired by McKesson for $1.1 billion. Other notable 2017 exits include Cleveland HeartLab to Quest Diagnostics, PartSource to Great Hill Partners, and Human Arc to Centauri Health Solutions.

In total, since 2002, the region has seen 67 medical device, biotech, and health IT & services exits.